About Malecare

Malecare is the world's leading men's cancer support and advocacy nonprofit organization.

Advanced Prostate Cancer Teleconference Is Available On-Line

The recent teleconference I had with Dr. James Mckiernan about advanced prostate cancer is now available to listen to on-line. Many people have been asking how to hear the conference, now you can. Go to the navigation bar above On the blog) and click on the teleconference tab. To listen to the call click on [...]

Presidential Proclamation–National Prostate Cancer Awareness Month

President Obama finally declares September as National Prostate Cancer Month A PROCLAMATION Although its mortality rate has steadily fallen in the last decade, prostate cancer is still the second leading cause of cancer deaths among men in the United States. This year alone, nearly 218,000 men will be diagnosed with prostate cancer, and more than [...]

Finally, CMS Announces A Meeting to Discuss Medicare Coverage for Provenge

The Center for Medicare and Medicaid Services (CMS), the U.S. agency in charge of Medicare, announced yesterday that it has scheduled a meeting to discuss the coverage of Dendreon’s prostate cancer vaccine Provenge. The meeting has been scheduled for this November 17. […]

Newly Diagnosed – Read Me

1) Start building personal medical file by getting every copy of medical procedure done on you, including the biopsy results, blood works, MRI, Bone scan and others. Patient have a right to demand a copy for each procedure and this will serve as your personal reference in the future to keep track of your own [...]

By |2017-10-19T10:53:42-04:00August 31st, 2010|Newly Diagnosed|1 Comment

Pamidronate or Zoledronic Acid – Is There A Difference In the End Results?

Pamidronate and zoledronic acid (bisphosphonates) are a mainstay in the treatment of men with advanced prostate cancer as well as for breast cancer survivors for the prevention of skeletal-related events (SREs). There have been many clinical trials comparing the efficacy and side effect profiles between pamidronate and zoledronic acid among men with advanced prostate cancer. [...]

Go to Top